Adults on Medicaid who began treatment for a new bout of low back pain with a higher-dose opioid prescription were about two and a half times as likely to later show signs of opioid use disorder or overdose, according to a study conducted at Columbia University Mailman School of Public Health and NYU Grossman School of Medicine.
❓ Unknown
Higher-Dose Opioid Prescriptions Linked to Increased Risk of Opioid Use Disorder
4d ago
October 28, 2026
1 min read
📰 Medical Xpress
📋 Key Takeaway
A study from Columbia University and NYU found that adults on Medicaid who started treatment for low back pain with higher-dose opioids were significantly more likely to develop opioid use disorder or overdose. This highlights the risks associated with opioid prescriptions. Understanding these trends is crucial for Iran as it grapples with its own healthcare challenges and substance abuse issues.
🔍 Quick Context Guide
💡 Bottom Line:
The study highlights the dangers of high-dose opioid prescriptions, a critical issue for healthcare systems worldwide, including Iran.
👥 Key Players
Columbia University Mailman School of Public Health
MENTIONED
Research Institution
"Their research contributes to understanding public health issues, including substance abuse, which is relevant for Iran's healthcare challenges."
NYU Grossman School of Medicine
MENTIONED
Research Institution
"Their findings help inform medical practices and policies, which can influence opioid prescription guidelines in Iran."
Medicaid
MENTIONED
Health Insurance Program
"As a significant healthcare provider, Medicaid's practices can serve as a model or warning for Iran's healthcare system."
📰 What Happened
A study found that adults on Medicaid prescribed higher doses of opioids for low back pain are significantly more likely to develop opioid use disorder or overdose. This raises concerns about opioid prescription practices.
- Higher-dose opioid prescriptions increase the risk of opioid use disorder by 2.5 times.
- The study specifically focused on adults receiving Medicaid.
💡 Why It Matters
🇮🇷 For Iran: Iran is dealing with its own substance abuse problems, and understanding the risks associated with opioid prescriptions can inform its healthcare policies.
🌍 Regional: The findings may encourage regional discussions on drug prescription practices and healthcare reforms.
🌐 International: Internationally, this study may influence global health policies regarding opioid use and addiction treatment.
📚 Background
Opioid use disorder is a growing public health crisis linked to prescription practices, with implications for addiction and overdose rates. Understanding these dynamics is essential for effective healthcare management.
Substance abuse
Healthcare policy
📡 Source:
NEUTRAL
📊 Confidence:
70%
The study is based on academic research, which typically aims for objectivity and is subject to peer review.
🏷️ Entities Mentioned
🌐
Translated from the original and edited for English readers. View original source →
Translation confidence: 100%
📰 Related Coverage
Just now •
Trump: Negotiations with Iran are progressing well but are not trustworthy
23 min ago •
Video/Javadi Amoli: If We Remove Any Opposing View from the Train of the Revolution, We…
25 min ago •
Admission to Witness Schools Based on Scores and Capacity/Details of Acceptance for Students in Exceptional…
39 min ago •
What Are Universities Around the World Doing for Proper Energy Consumption?
39 min ago •